Systemic hypertension is a common condition associated with significant morbidity and mortality. Hypertension confers cardiovascular risk by causing target-organ damage that includes retinopathy in addition to heart disease, stroke, renal insufficiency and peripheral vascular disease. The recognition of hypertensive retinopathy is important in cardiovascular risk stratification of hypertensive individuals. This review reevaluates the changing perspectives in the pathophysiology, classification and prognostic significance of fundal lesions in hypertensives.
Introduction
Hypertension produces cardiovascular risk by causing end-organ damage that includes retinopathy. 1 Current studies have shown that the effects of systemic hypertension on the retinal, optic nerve head and choroidal circulation produce three distinct and independent manifestations: (i) hypertensive retinopathy, (ii) hypertensive optic neuropathy, and (iii) hypertensive choroidopathy. 2, 3 The established classification techniques for grading hypertensive retinopathy have poor correlation with the severity of hypertension. 2 Large populationbased studies suggest that fundus lesions described in hypertensive individuals may also occur in nonhypertensives. [4] [5] [6] [7] Poorly controlled systemic hypertension causes worsening of microvascular disease of the eye like diabetic retinopathy. [8] [9] [10] Systemic hypertension is associated with a number of ocular conditions although the exact causal relationships are yet to be fully defined.
Aetiology
Race: Afro-Caribbeans have a higher prevalence of hypertension and hypertensive retinopathy than Europeans but the relationship between hypertension and the prevalence of retinopathy is poorer amongst Afro-Caribbeans. 11 The relationship is strongest for European women and weakest for Afro-Caribbean women.
11
Sex: The prevalence of hypertensive retinopathy is higher in women than in men.
Smoking: Though the true association between smoking, hypertension and target-organ damage is difficult to assess due to the confounding effects of other life-style and socio-economic factors, studies focusing on malignant hypertension have shown a strong association between smoking and grade IV hypertensive retinopathy. [12] [13] [14] [15] [16] Genetic factors: Certain specific genotypes are linked with an increased risk of hypertensive retinopathy. The D (deletion) allele of the angiotensin converting enzyme (ACE) gene is an independent risk factor for the development of end-organ damage in patients with essential hypertension 17 and entails a 2.4-fold higher chance of retinopathy. 18 The hypertensive individuals who carry the apoepsilon4 allele of apolipoprotein E gene or are homozygous carriers of a point mutation (cytosine to thymidine substitution) in the gene encoding 5,10-methylenetetrahydrofolate reductase (IT polymorphism) are at a significantly higher risk of retinopathy. 19, 20 A Turkish kindred of autosomal dominant monogenic hypertension has been described, where the affected individuals have brachydactyly and are 10 cm shorter than the unaffected individuals. They had no retino-pathy, despite very early onset of severe hypertension. 21 Renal status: In patients with essential hypertension, persistent microalbuminuria is a marker of early end-organ damage including retinopathy. 22, 23 Patients with retinal vascular changes were shown to have a significantly lower glomerular filtration rate as indicated by creatinine clearance. 22 Cardiac status: Left ventricular hypertrophy and retinal vascular disease appear early in the course of blood pressure elevation and both changes develop in parallel. 24 The severity of hypertensive retinopathy and the renal involvement are more severe in patients with concentric rather than eccentric left ventricular hypertrophy. 25 It is postulated that predominantly volume overload, resulting in eccentric left ventricular hypertrophy is less likely to cause extracardiac target-organ damage. 26 Plasma leptin: A critical plasma leptin level for the development of retinopathy has been identified (10.2 ng/ml). 27 Leptin, an angiogenesis factor, was significantly higher in patients with grade 1 retinopathy even after correction for body mass index. 27 The elevated concentrations possibly relate to the damage of the vascular endothelium by high blood pressure. 27 Salt sensitivity: Hypertensive retinopathy is more common in salt-sensitive hypertension than in saltresistant hypertension. 28 Secondary hypertension: Renal hypertension secondary to focal segmental sclerosis and membranoproliferative glomerulonephritis is associated with more severe retinopathy than essential hypertension. The hypertensive retinopathy deteriorates as the renal disease progresses. 29 Atherosclerotic renovascular disease is associated with high-grade retinopathy. 30 Severe end-organ damage including grade III or IV retinopathy is common in hypertension secondary to pheochromocytoma. 31 No difference, however, is seen in the prevalence of malignant hypertension, between malignant and nonmalignant pheochromocytomas. 32 In primary hyperaldosteronism hypertensive retinopathy is usually less severe. 26 Refractory hypertension: Refractory hypertension is associated with a high prevalence of target-organ damage at cardiac, macro-and microvascular level with advanced retinal involvement (grades II and III retinopathy). 33 
Pathophysiology
Retinal microvasculature: A cross-sectional study on retinal microvasculature has demonstrated a lower number of perifoveal arterioles and venules in hypertensives. 34 Decreasing perifoveal capillary flow velocity is seen in patients with essential hypertension despite adequate blood pressure control. 35 Measurements of bifurcation angles and retinal arteriolar diameters in response to acute hyperoxic and hypercapneic stress have demonstrated diminished vascular reactivity in hypertensive subjects. 36 Hypertension may be associated with a disadvantageous branching geometry in the retinal vasculature, with reduced circulatory efficiency and microvascular rarefaction. 37 Dynamics of ocular blood flow: The ocular and optic nerve head blood flow is directly related to perfusion pressure (mean arterial pressure minus intraocular pressure) and inversely related to the resistance to flow. 2 Resistance to blood flow depends upon the state and calibre of the ocular arteries and is influenced by hypertensive arterial changes and the efficiency of the autoregulation of the blood flow. 2 Autoregulation maintains a constant ocular blood flow to tissues during changes in perfusion pressure. Endothelial-derived molecules, ie; endothelins, thromboxane A2, prostaglandins and nitric oxide play a role in autoregulation by modulating vascular tone. 38 Breakdown of autoregulation occurs with rise or fall of perfusion pressure beyond a critical range. In hypertensives, where the autoregulation range is set to higher levels, episodic hypotension (spontaneously, as during sleep or due to overtreatment), changes in the tone of the precapillary arterioles (mediated by angiotensin or antihypertensive drugs) and vascular endothelial changes (leading to reduced nitric oxide synthesis) lead to breakdown of autoregulation. [39] [40] [41] The tight junctions of the retinal endothelium and the retinal pigment epithelium form the inner and outer blood-retinal barriers. Acute hypertension causes disruption of the blood-retinal barriers. 2 The retinal and optic nerve head vascular beds have autoregulation but the choroidal vascular bed does not. 2 The fenestrated choroidal vessels do not have a blood-ocular barrier. 2 The retinal vessels are devoid of an autonomic nerve supply but the choroidal vessels are richly supplied by both sympathetic and parasympathetic nerves. 2 The different anatomical and physiological properties of the retinal, optic nerve head and choroidal blood vessels produces three distinct and unrelated manifestations, ie retinopathy optic neuropathy and choroidopathy. 2 
Hypertensive retinopathy

Definition
Hypertensive retinopathy represents target-organ damage in patients with high systemic arterial blood pressure and was first described by Liebreich in 1859. 42 
Classification
The classification of hypertensive retinopathy is shown in Table 1 . Current literature challenges the prognostic significance of the early graded classifications of hypertensive retinopathy by Keith-Wagener-Barker and Scheie. [43] [44] [45] The poor correlation with the severity of hypertension, variation in the onset and progression of the clinical signs, and recognition of optic neuropathy and choroidopathy as independent entities have prompted some investigators to stress the importance of describing fundal appearance rather than assigning a grade. 2 A simple two-grade classification of retinopathy into nonmalignant (nonaccelerated) vs malignant (accelerated) has been proposed that provides a useful correlation between clinical features and prognosis. 43 A similar classification has been suggested to encourage the utilisation of the eye as a hypertensive target organ for risk stratification and therapeutic decision making. 46 The significant angiographic differences in the density of the perifoveal capillaries and capillary blood velocity between mild and severe forms of hypertensive retinopathy correlate with a two-grade rather than four-grade classification system. 47 
Clinical features
The primary response of the retinal arterioles to systemic hypertension is vasoconstriction. Sustained hypertension leads to disruption of the blood-retinal barrier, increased vascular permeability and secondary arteriolosclerosis.
The fundus features commonly described in hypertensive retinopathy 45 include focal and generalised arteriolar narrowing, microaneurysms, intraretinal haemorrhages, cotton-wool spots, hard exudates and optic disc swelling. Changes of secondary arteriolosclerosis are arteriovenous nipping, changes in the arteriolar light reflex and arteriolar sheathing and occlusion. 45 Clinically focal arteriolar narrowing is easier to assess than generalised narrowing but with new computer-assisted quantification, generalised retinal arteriolar narrowing can be ascertained reliably by standardised photographic grading methods. 48 Abnormal vascular permeability produces flameshaped haemorrhages, retinal oedema and lipid exudates. 49 The deeper blot haemorrhages appear with progression of hypertension and indicate worsening ischaemia. 49 Deposition of lipid around the fovea may lead to the formation of a macular star 50 ( Figure 1a ). Acute hypertension may cause obstruction of the precapillary arterioles and development of nerve fibre layer infarcts (cotton-wool spots) or swelling of the optic disc. 50 Severe acute hypertension may present with a macular star and disc swelling in the presence of minimal microvascular change and can be confused with neuroretinitis, papilloedema secondary to raised intracranial pressure or Leber's stellate maculopathy. 50 Complications of severe untreated hypertension include haemorrhagic detachment of the internal limiting membrane of the retina, subhyaloid and vitreous haemorrhage 50 ( Figure 1b ). Secondary arteriolosclerosis of the common vascular adventitial sheath, at the level of the arteriovenous crossing, produces compression of the venule. 49 Arteriovenous crossing changes include banking of the venule distal to the crossing (Bonnet's sign), nipping of the blood column (Gunn's sign) and displacement of the venule at right angles to the arteriole (Salus's sign). 49 The increased arteriolar light reflex correlates with hyalinisation of the arteriolar wall. Obscuration of the red blood cell column with copper wire or silver wire appearance of the light reflex has classically been described in grade II or III retinopathy, respectively. 49 Most features of acute hypertensive retinopathy regress over 6-12 months with timely antihypertensive therapy 51 ( Figures 1c and d) . Despite resolution of fundus signs, in one study electroretinogram recordings continued to remain abnormal up to 2-4 years following the acute episode. 52 In the animal model, the early signs of acute hypertensive retinopathy were focal intraretinal periarteriolar transudates, cotton-wool spots, retinal haemorrhages and oedema. 2 Retinal arteriolar changes, cystoid macular changes, hard exudates and nerve fibre loss were late manifestations. 2 Retinal arteriolar spasm, a typical finding of malignant hypertension in humans, was described as an ophthalmoscopic artefact produced by retinal oedema masking the arterioles from the sides (pseudo-narrowing). 2 In the absence of the characteristic clinical signs fluorescein angiography is useful for delineation of the microvascular abnormalities. 53 
Arteriolosclerosis or hypertensive retinopathy?
Several epidemiological studies have described retinal microvascular abnormalities in nondiabetic hypertensive and normotensive populations. The Blue Mountain Eye Study 6 found a prevalence of Hypertension and the eye: perspectives S Chatterjee et al retinopathy, defined as retinal microaneurysms and haemorrhages, of 9.8% in older nondiabetic subjects. These were significantly related to the presence and severity of hypertension but only 42% of these lesions could be explained by hypertension. The Beaver Dam Eye Study 3-5 described arteriolar narrowing, arteriovenous nicking and retinopathy in both nondiabetic hypertensive and normotensive individuals. The predictive value for systemic hypertension was 47% when any retinopathy was present and 53% when arteriovenous nicking was present. Therefore, 47-63% of people in the study with arteriolar narrowing, arteriovenous nicking or retinopathy did not have hypertension. The atherosclerosis risk in communities study 54 found that in nondiabetic individuals both arteriovenous nicking and generalised arteriolar narrowing were strongly and monotonically related to current and past blood pressure, irrespective of antihypertensive medication. Abnormalities of the retinal vasculature therefore may reflect microvascular damage due to hypertension or arteriolosclerosis or both.
Hypertensive optic neuropathy
Papilloedema or bilateral disc swelling represents grade IV hypertensive retinopathy in the KeithWagener-Barker classification. 55 It was considered an essential criterion of malignant hypertension. 55 Traditionally papilloedema in hypertension has been considered to be a poor prognostic sign for survival. 55 Other clinical 56 and experimental 39, 57 studies have refuted the prognostic significance of papilloedema. These studies concluded that papilloedema was not a necessary feature of malignant hypertension. The WHO criterion for malignant hypertension is severe hypertension with bilateral retinal haemorrhages and exudates. 58 Conversely, it has been suggested that in the presence of elevated systemic blood pressure, isolated papilloedema without retinopathy could represent a variant of malignant hypertension. 59 Other causes of papilloedema like space-occupying lesions and benign intracranial hypertension, however, need to be excluded. 59 The pathogenesis of papilloedema secondary to systemic hypertension is controversial and the several theories include: 2 (i) ischaemia, (ii) raised intracranial pressure, and (iii) as a part of hypertensive retinopathy/encephalopathy. Both clinical studies using visual evoked potentials and electroretinogram recordings in accelerated hypertension 52 and experimental animal studies 39, 57 found ischaemia to be the possible underlying mechanism. Papilloedema secondary to hypertension usually Hypertension and the eye: perspectives S Chatterjee et al resolved following good control of blood pressure although some developed disc pallor. 52 Longstanding chronic hypertension may result in retinal nerve fibre loss. 60 
Hypertensive choroidopathy
Choroidal lesions secondary to elevated blood pressure are less well recognised than retinopathy in the current literature. The underlying mechanism relates to choroidal ischaemia and its effects on the retinal pigment epithelium and retina. 40 The more commonly described features of hypertensive choroidopathy are choroidal vascular sclerosis, Elschnig spots representing focal areas of degenerative retinal pigment epithelium (Figure 2 ) and the diffuse patchy atrophic retinal pigment epithelial degeneration of chronic hypertensions. 61, 62 Siegrist's streaks, linear retinal pigment epithelial changes, are the sequelae of acute hypertensive choroidopathy and generally indicative of a poor prognosis. 63 Serous retinal detachment, a prominent feature in the animal model, is less common in clinical settings. 64, 65 Ocular diseases secondary to systemic hypertension Systemic hypertension has been associated with a large number of ophthalmic conditions. They are described briefly in the context of the current literature.
Retinal vein occlusion
Retinal vein occlusions occur most commonly at the level of the lamina cribrosa (central or hemispheric retinal vein occlusion) or at an arteriovenous crossing (branch retinal vein occlusion). 66, 67 They commonly present with sudden painless visual loss or a field defect. The signs in the acute phase may include engorged tortuous retinal veins, superficial flame retinal haemorrhages, retinal oedema, cottonwool spots and disc swelling 66 ( Figure 3 ). Central retinal vein occlusions are clinically divided into nonischaemic and ischaemic. 66 In the presence of persisting retinal nonperfusion, neovascularisation may develop on the disc, retina or iris. Treatment with laser photocoagulation is indicated in these cases. 66, 67 If untreated, sight-threatening complications such as vitreous haemorrhage and secondary rubeotic glaucoma may develop. 66 Several studies have demonstrated that systemic hypertension is associated with an increased risk of developing central, branch and hemi-central retinal vein occlusions. [68] [69] [70] Systemic hypertension was also found to be associated with branch macular vein occlusions in younger patients. 71 A recent study 72 found a significantly higher prevalence of arterial hypertension in branch retinal vein occlusion compared with central and hemi-central retinal vein occlusion. Arterial hypertension was also more likely to be present in ischaemic rather than nonischaemic central retinal vein occlusion. 72 
Retinal arterial macroaneurysm
Retinal arterial macroaneurysms are acquired focal aneurysmal dilatations of the retinal arterioles, usually occurring in the first three orders of the arteriolar tree. 73 They are commonly seen in hypertensive retinopathy giving rise to starshaped exudation and sometimes complicated by Hypertension and the eye: perspectives S Chatterjee et al pre-retinal or intravitreal haemorrhage. 73, 74 Spontaneous resolution with thrombosis within the macroaneurysm may occur 73 ( Figure 4 ). In the presence of active leakage laser photocoagulation may be applied directly to the macroaneurysm. 73 
Non-arteritic anterior ischaemic optic neuropathy
Essential arterial hypertension is significantly associated with non-arteritic anterior ischaemic optic neuropathy. 75 Clinically, this presents with unilateral painless disc swelling followed by disc pallor and irreversible visual loss. 76 Symptoms may include a classical altitudinal field defect or a central scotoma. 76 The exact mechanism may be chronic hypoperfusion of the small end-arterial optic nerve head vessels caused by over-treated hypertension or abnormal vascular autoregulation. 77 Recent studies have suggested that ocular or optic nerve head ischaemic disorders may be due to a combination of systemic arterial hypertension and hypotension. [78] [79] [80] Cranial nerve palsies
Cranial nerve palsies, including third, fourth, sixth and seventh cranial nerve palsies, are commonly found secondary to systemic hypertension. [81] [82] [83] [84] They are often isolated events causing acute symptomatic diplopia. 85 They usually resolve spontaneously within three months. 85 Neuroimaging may not be indicated in the absence of other neurological signs or pupillary abnormalities. 85 
Diabetic retinopathy
Diabetic retinopathy is a microvascular disorder in which endothelial cell malfunction and impaired regulation of retinal perfusion occur owing to chronic glucotoxicity. 86 UKPDS 50 demonstrated that the incidence of diabetic retinopathy was strongly associated with higher blood pressure. 87 UKPDS, EUCLID and other studies have shown retardation in the progression of diabetic retinopathy with improved control of blood pressure. 88 The HOPE study results showed that it was both safe and beneficial to lower BP already within the 'normal' range with angiotensin converting enzyme inhibitors in patients with known vascular risk factors including left ventricular dysfunction, hypertension or diabetic microalbuminuria. 89 
Conclusion
Hypertensive retinopathy, neuropathy and choroidopathy represent target-organ damage in persons with systemic arterial hypertension. Hypertensive retinopathy in particular is a recognised cardiovascular risk stratification factor. Prompt recognition and accurate diagnosis of hypertensive retinopathy, neuropathy and choroidopathy have important implications for both the ocular and general health of the individual.
